Tim Holden
Head of Pharma Services

Is this your profile?

About

Tim Holden has 35 years’ experience in pharma and medical device commercial leadership with a pharma licensing background across multiple therapy areas. He is presently heading Pharma Services for Owen Mumford ensuring combination products in the company’s drug delivery platforms are successfully partnered.

Contributions

SMARTER FOR BUDGETS & KINDER TO THE PLANET: ECOSAFE^® SAFETY SYRINGE PLATFORM

Tim Holden describes the key objectives behind Owen Mumford’s 1 mL safety syringe injection platform and how the company sought to provide a single platform for all patients (able, less dexterous and needle-phobic) while minimising cost, waste and carbon footprint impact.

More contributions

PREFILLED SYRINGES

USING POLYMERIC PDC TECHNOLOGY TO IMPROVE AUTO-INJECTOR DESIGN

The limitations of using glass-based auto-injectors, such as contamination, and the need for delivering complex, viscous preparations, have led to a new approach that uses polymeric PDC technology instead. Jonathan Lawson, Jonathan Bradshaw and Susie White look at what polymeric PDCs can offer in making auto-injectors truly patient-centric.

Top